P2RY1 and prostate carcinoma: PC3 and DU-145 hormone refractory prostate cancer cells, which have a similar expression profile (P2X4,5,7, P2Y1,2,4,6) to estrogen and progesterone insensitive MDA-MB-468 breast cancer cells, undergo growth inhibition in response to ATP stimulation [36].